As is the case with EGFR amplification, diffuse gliomas formerly classified as IDH-wildtype grade 2–3 diffuse astrocytomas with TERT promoter mutations are now classified as glioblastomas, IDH-wildtype (5). This evidence concerns the gene EGFR and glioblastoma.